Found 18 matching trials
Anlotinib Combined With Concurrent Chemoradiotherapy in the Treatment of Locally Advanced Cervical Cancer PHASE2 To observe the efficacy and safety of hydrochloride anlotinib combined with...
Show More Location
Multiple Locations
Learn More & Join Trial
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032) PHASE3 Researchers are looking for new ways to treat types of breast cancer that a...
Show More Location
Banner MD Anderson Cancer Center ( Site 0066)
Learn More & Join Trial
Ascorbic Acid and Chemotherapy for the Treatment of Relapsed or Refractory Lymphoma, CCUS, and Chronic Myelomonocytic Leukemia PHASE2 This phase II trial studies the effect of ascorbic acid and combination che...
Show More Location
Mayo Clinic Health Systems-Mankato
Learn More & Join Trial
Taste Alteration, Sarcopenia, and Malnutrition in Gynecologic Cancer Patients Receiving Carboplatin-Paclitaxel Chemotherapy N/A This observational study aims to evaluate chemotherapy-induced taste altera...
Show More Location
Ankara Etlik City Hospital
Learn More & Join Trial
A Study to Learn About the Study Medicine PF-07985045 When Given Alone or With Other Anti-cancer Therapies in People With Advanced Solid Tumors That Have a Change in a Gene. PHASE1 The purpose of this study is to learn about the safety and effects of the s...
Show More Location
Highlands Oncology Group
Learn More & Join Trial
Study on the Association of GSTP1 and Other Gene Polymorphisms With Platinum-induced Myelosuppression N/A This study intends to design a retrospective and prospective, cohort study ...
Show More Location
Multiple Locations
Learn More & Join Trial
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer PHASE3 DESTINY-Endometrial01 will investigate the efficacy of first-line T-DXd + r...
Show More Learn More & Join Trial
Icotinib as the Adjunctive Treatment After Surgery in Stage I-IIIB Lung Adenocarcinoma Patients With EGFR Gene Mutation PHASE4 This is a randomized ,opened, prospective controlled trial of clinical effe...
Show More Location
PLA General Hospital
Learn More & Join Trial
Re-Radiochemotherapy and Pembrolizumab vs. Immuno(Chemo)Therapy for Locoregionally Recurrent PD-L1 Positive (CPS≥1) HNSCC PHASE3 Prospective, open-label, randomized controlled phase III trail that aims to...
Show More Location
Klinikum Chemnitz gGmbH, Klinik für Radioonkologie
Learn More & Join Trial
Concurrent Radiochemotherapy Plus Anlotinib for Locally Advanced Cervical Cancer NA To observe the efficacy and safety of hydrochloride anlotinib combined with...
Show More Location
Zhongnan Hospital of Wuhan University
Learn More & Join Trial